key points: supposedly Prostact to be rolled out in the US in the next 6 months. (This would have been a question from me)
Renal cancer approval process looks like starting late this year. I'd expect about a year for approval (let's see how much orphan designation really helps) so end 2023.
"Quarterly reporting" of Illucix sales means, I guess, we'll know what's happening at end of July (when the 4C comes out).
Ann: Chairman's Address to Annual General Meeting, page-5
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.96 |
Change
0.960(4.57%) |
Mkt cap ! $7.349B | |||
| Open | High | Low | Value | Volume |
| $21.50 | $21.97 | $21.08 | $22.91M | 1.059M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $21.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.96 | 205 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| TLX (ASX) Chart |